To award c-04, chemistry and manufacturing services. The period of performance is june 21, 2019 to june 20, 2020
Ended Awarded Last action
- Contract number
- 75N93019F00134
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $144,154
Award facts
- Opportunity
-
- NIHAI2017090 Solicitation number
- Nonclinical Services for Development of Interventional Agents for Infectious Diseases Award Notice · Posted Feb 13, 2017
- Contract value 100% obligated
- $144,154.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $16,534 | |
| Exercise an Option | $37,487 | |
| Exercise an Option | $21,685 | |
| Exercise an Option | $21,174 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $47,274 |
About this award
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, and was awarded to Sri International, a non-profit research institute. The contract, valued at $144,154.00, is for delivery order C-04, which provides chemistry and manufacturing services. The period of performance is from June 21, 2019 to June 20, 2020, with a completion date of December 14, 2023. The contract type is cost plus fixed fee, and there was no set-aside used. Sri International has a history of providing a wide range of research, development, and advisory services to government agencies, including the Department of Defense, Department of Health and Human Services, Department of Education, and NASA, through both prime and subcontractor roles.
Quick answers
Who was awarded contract 75N93019F00134?
75N93019F00134 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 21, 2019.
How much is contract 75N93019F00134 worth?
The government has obligated $144,154 on 75N93019F00134.
Is contract 75N93019F00134 an order under another contract?
Yes. 75N93019F00134 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93019F00134 competed?
The extent of competition for 75N93019F00134 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award